Research and Development

No one looks forward to receiving a letter from the MHRA (Medicines and Healthcare products Regulatory Agency) inspectorate announcing their …

Adventrx completes enrolment for breast cancer trialAdventrx Pharmaceuticals has completed patient enrolment in its Phase II clinical trial of CoFactor …

There is a tide of change in drug safety within the pharmaceutical industry.  Internal and external forces are pushing drug …

Sanofi-Aventis has increased its stake in Regeneron and will collaborate with the US biotech company on new antibody research.The companies …

Medivir to initiate Phase IIa study of hepatitis CMedivir has announced that a Phase IIa study for its investigational hepatitis …

Pfizer is to acquire a company developing new drugs that fight diseases by altering the immune system. The company is …

Aeterna completes enrollment for Phase II trial of lung cancerAeterna Zentaris has completed patient recruitment for its European multi-center Phase …

Efforts to cut unnecessary delays to UK clinical trials have taken a step forward with a new agreement to help …

Fierce generic competition, price containment regulations and poor pipeline productivity are challenges looming over many pharmaceutical companies today. In effect, …

Abraxis gets FDA approval for chemotherapy drugAbraxis Pharmaceutical Products, the hospital-based business of Abraxis BioScience, has received FDA approval to …

Advaxis cancer vaccine shows encouraging resultsBiotechnology company Advaxis has announced positive results from a Phase I/II first-in-man trial of a …

Pfizer has unveiled its new strategy in research and development, including senior appointments and the setting up of an independent …

Scientists with novel ideas for research into some of the world's biggest diseases are to be offered a new source …